According to the algorithm, the levels of AXL, EPHA2, MET and PXN expression were greater in NSCLC, the expression of RON was greater in SCLC, and the model predicted no difference in levels of FAK expression between NSCLC and SCLC. The gene discussed is EPHA2; the disease is small cell lung carcinoma.